Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Fernando Mendive, Cecile Giovannetti & Sara García Arce. (2023) Ancient medicine for a modern disease: traditional Amazonian medicine to treat substance use disorders. The American Journal of Drug and Alcohol Abuse 49:6, pages 691-704.
Read now
Read now
Ismael Apud, Juan Scuro, Ignacio Carrera & Andrés Oliveri. (2023) Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay. Journal of Psychoactive Drugs 55:2, pages 141-150.
Read now
Read now
Ayotunde B. Omotoso, Alfred B. Makanjuola & Olatunji A. Abiodun. (2021) Recreational use of psychoactive substances among secondary school students in North-Central Nigeria. Journal of Substance Use 26:1, pages 73-78.
Read now
Read now
Ismael Eduardo Apud Peláez. (2020) Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca. Journal of Psychoactive Drugs 52:3, pages 264-272.
Read now
Read now
Alexandra VSL Rodrigues, Francisco Jcg Almeida & Maria A Vieira-Coelho. (2019) Dimethyltryptamine: Endogenous Role and Therapeutic Potential. Journal of Psychoactive Drugs 51:4, pages 299-310.
Read now
Read now
Andrew Kristoffer Dean. (2019) The enchanted snake and the forbidden fruit: the ayahuasca ‘fairy tale’ tourist. Journal of Marketing Management 35:9-10, pages 818-844.
Read now
Read now
Joselaine Ida Cruz & Solange Aparecida Nappo. (2018) Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?. Journal of Psychoactive Drugs 50:3, pages 247-255.
Read now
Read now
Amanda A. Nunes, Rafael G. dos Santos, Flávia L. Osório, Rafael F. Sanches, José Alexandre S. Crippa & Jaime E. C. Hallak. (2016) Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans. Journal of Psychoactive Drugs 48:3, pages 195-205.
Read now
Read now
Anja Loizaga-Velder & Rolf Verres. (2014) Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Substance Dependence—Qualitative Results. Journal of Psychoactive Drugs 46:1, pages 63-72.
Read now
Read now
Rafael Guimarães dos Santos. (2013) Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology. Journal of Psychoactive Drugs 45:1, pages 68-78.
Read now
Read now
Beatriz Caiuby Labate. (2012) Paradoxes of ayahuasca expansion: The UDV–DEA agreement and the limits of freedom of religion. Drugs: Education, Prevention and Policy 19:1, pages 19-26.
Read now
Read now
Beatriz
Caiuby Labate. (2011) Consumption of Ayahuasca by Children and Pregnant Women: Medical Controversies and Religious Perspectives. Journal of Psychoactive Drugs 43:1, pages 27-35.
Read now
Read now
Anette Kjellgren, Anders Eriksson & Torsten Norlander. (2009) Experiences of Encounters with Ayahuasca—“the Vine of the Soul”. Journal of Psychoactive Drugs 41:4, pages 309-315.
Read now
Read now
Paulo
Cesar Ribeiro Barbosa, Irene
Maurício Cazorla, Joel
Sales Giglio & Rick Strassman. (2009) A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naïve Subjects. Journal of Psychoactive Drugs 41:3, pages 205-212.
Read now
Read now
Stephen Trichter, Jon Klimo & Stanley Krippner. (2009) Changes in Spirituality Among Ayahuasca Ceremony Novice Participants. Journal of Psychoactive Drugs 41:2, pages 121-134.
Read now
Read now
Evelyn Doering-Silveira, Enrique Lopez, CharlesS. Grob, Marlene
Dobkin de Rios, LuisaK. Alonso, Cristiane Tacla, Itiro Shirakawa, PauloH. Bertolucci & DartiuX. Da Silveira. (2005) Ayahuasca in Adolescence: A Neuropsychological Assessment. Journal of Psychoactive Drugs 37:2, pages 123-128.
Read now
Read now
Articles from other publishers (67)
Fahd François Hilal, Jerome Jeanblanc, Chloé Deschamps, Mickael Naassila, Olivier Pierrefiche & Sami Ben Hamida. (2024) Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies. Journal of Neural Transmission 131:5, pages 525-561.
Crossref
Crossref
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow & Rachel Yehuda. (2024) The Psychedelic Future of Post-Traumatic Stress Disorder Treatment. Current Neuropharmacology 22:4, pages 636-735.
Crossref
Crossref
Hector Vargas-Perez, Fernando Minauro-Sanmiguel, Ryan Ting-A-Kee, Taryn Elizabeth Grieder, Mónica Méndez-Díaz, Oscar Prospéro-García & Derek van der Kooy. (2024) Rewarding Effects of the Hallucinogen 4-AcO-DMT Administration and Withdrawal in Rats: A Challenge to the Opponent-Process Theory. Neuroscience Letters 820, pages 137597.
Crossref
Crossref
Rafael G. dos Santos & Jaime E.C. Hallak. 2024. Interventional Psychiatry. Interventional Psychiatry
357
382
.
Juan Scuro. (2023) Los abordajes de las adicciones como un campo de convergencia entre estudios sobre religión, espiritualidad, salud y drogas. Ciencias Sociales y Religión 25, pages e023020.
Crossref
Crossref
Simon G. D. Ruffell, Max Crosland‐Wood, Rob Palmer, Nige Netzband, WaiFung Tsang, Brandon Weiss, Sam Gandy, Tessa Cowley‐Court, Andreas Halman, Diana McHerron, Angelina Jong, Tom Kennedy, Eleanor White, Daniel Perkins, Devin B. Terhune & Jerome Sarris. (2023) Ayahuasca: A review of historical, pharmacological, and therapeutic aspects. Psychiatry and Clinical Neurosciences Reports 2:4.
Crossref
Crossref
Atsuko Kawakami & Masako Suzuki. (2023) Ayahuasca in Western society and the metacognitive counselling approach. Counselling and Psychotherapy Research 23:4, pages 1134-1143.
Crossref
Crossref
Anna Beatriz Vicentini, Lucas Silva Rodrigues, Giordano Novak Rossi, Juliana Mendes Rocha, Lorena T. L. Guerra, José Augusto Silva Reis, Renan Massanobu Maekawa, Flávia de Lima Osório, José Carlos Bouso, Fabiana Pereira Santos, Beatriz Aparecida Passos Bismara Paranhos, Mauricio Yonamine, Jaime Eduardo Cecilio Hallak & Rafael Guimarães dos Santos. (2023) Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts. Psychoactives 2:4, pages 346-358.
Crossref
Crossref
Omer A. Syed, Benjamin Tsang, Rotem Petranker & Robert Gerlai. (2023) A perspective on psychedelic teratogenicity: the utility of zebrafish models. Trends in Pharmacological Sciences 44:10, pages 664-673.
Crossref
Crossref
Dimitri Daldegan-Bueno, Natalia Maria Simionato, Vanessa Manchim Favaro & Lucas Oliveira Maia. (2023) The current state of ayahuasca research in animal models: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 125, pages 110738.
Crossref
Crossref
Lucas Oliveira Maia, Dimitri Daldegan-Bueno, Isabel Wießner, Draulio B. Araujo & Luís Fernando Tófoli. (2023) Ayahuasca's therapeutic potential: What we know – and what not. European Neuropsychopharmacology 66, pages 45-61.
Crossref
Crossref
Javier Calleja‐Conde, Jose Angel Morales‐García, Víctor Echeverry‐Alzate, Kora Mareen Bühler, Elena Giné & Jose Antonio López‐Moreno. (2022) Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies. Addiction Biology 27:6.
Crossref
Crossref
Daniel Perkins, Broc A. Pagni, Jerome Sarris, Paulo C. R. Barbosa & Richard Chenhall. (2022) Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study. Frontiers in Pharmacology 13.
Crossref
Crossref
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes & Renato Filev. (2022) Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research. Addiction Neuroscience 3, pages 100025.
Crossref
Crossref
Lucas Silva Rodrigues, Giordano Novak Rossi, Juliana Mendes Rocha, Flávia L Osório, José Carlos Bouso, Jaime E. Cecílio Hallak & Rafael G. dos Santos. (2021) Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies. European Archives of Psychiatry and Clinical Neuroscience 272:4, pages 541-556.
Crossref
Crossref
Anne K Schlag, Jacob Aday, Iram Salam, Jo C Neill & David J Nutt. (2022) Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology 36:3, pages 258-272.
Crossref
Crossref
Daniel Perkins, Emerita S. Opaleye, Hana Simonova, José C. Bouso, Luís F. Tófoli, Nicole L. GalvÃo‐Coelho, Violeta Schubert & Jerome Sarris. (2021) Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross‐sectional survey. Drug and Alcohol Review 41:1, pages 265-274.
Crossref
Crossref
Sahar Jaffal & Husam Abazid. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
389
414
.
Sahar Jaffal & Husam Abazid. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
26
.
Matthew W. Johnson. 2022. Disruptive Psychopharmacology. Disruptive Psychopharmacology
213
227
.
Michael Koslowski, Matthew W. Johnson, Gerhard Gründer & Felix Betzler. (2021) Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy. Current Addiction Reports 9:1, pages 48-58.
Crossref
Crossref
Lukas A. Basedow, Thomas G. Riemer, Simon Reiche, Reinhold Kreutz & Tomislav Majić. (2021) Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Keri Mans, Hannes Kettner, David Erritzoe, Eline C. H. M. Haijen, Mendel Kaelen & Robin L. Carhart-Harris. (2021) Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample. Frontiers in Psychiatry 12.
Crossref
Crossref
Kabir B. Nigam & Ananda K. Pandurangi. (2021) Do Hallucinogens Have a Role in the Treatment of Addictions? A Review of the Current Literature. SN Comprehensive Clinical Medicine 3:6, pages 1385-1395.
Crossref
Crossref
H. Kettner, F. E. Rosas, C. Timmermann, L. Kärtner, R. L. Carhart-Harris & L. Roseman. (2021) Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness. Frontiers in Pharmacology 12.
Crossref
Crossref
Rebecca O. Soremekun, Oluwakemi E. Omole, Oluwatosin C. Adeyemi & Abayomi M. Oshatimi. (2021) Assessment of use of psychoactive and other non-prescription drugs among students of selected tertiary institutions in Ekiti State South West Nigeria - A baseline study. Heliyon 7:2, pages e06232.
Crossref
Crossref
Collin M. ReiffElon E. RichmanCharles B. NemeroffLinda L. CarpenterAlik S. WidgeCarolyn I. RodriguezNed H. KalinWilliam M. McDonald. (2021) Psychedelics and Psychedelic-Assisted Psychotherapy. FOCUS 19:1, pages 95-115.
Crossref
Crossref
Natasha L. Mason & Kim P. C. Kuypers. 2021. Ayahuasca Healing and Science. Ayahuasca Healing and Science
117
136
.
Marta Valle, Elisabet Domínguez-Clavé, Matilde Elices, Juan Carlos Pascual, Joaquim Soler, José A. Morales-García, Ana Pérez-Castillo & Jordi Riba. 2021. Ayahuasca Healing and Science. Ayahuasca Healing and Science
1
19
.
Collin M. ReiffElon E. RichmanCharles B. NemeroffLinda L. CarpenterAlik S. WidgeCarolyn I. RodriguezNed H. KalinWilliam M. McDonald. (2020) Psychedelics and Psychedelic-Assisted Psychotherapy. American Journal of Psychiatry 177:5, pages 391-410.
Crossref
Crossref
Laura Orsolini, Stefania Chiappini, Duccio Papanti, Roberto Latini, Umberto Volpe, Michele Fornaro, Carmine Tomasetti, Federica Vellante & Domenico De Berardis. (2020) How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy. Human Psychopharmacology: Clinical and Experimental 35:3.
Crossref
Crossref
Edgar Antonio Estrella-Parra, Julio Cesar Almanza-Pérez & Francisco Javier Alarcón-Aguilar. (2019) Ayahuasca: Uses, Phytochemical and Biological Activities. Natural Products and Bioprospecting 9:4, pages 251-265.
Crossref
Crossref
Matthew W. Johnson, Peter S. Hendricks, Frederick S. Barrett & Roland R. Griffiths. (2019) Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics 197, pages 83-102.
Crossref
Crossref
Lindsay P. Cameron & David E. Olson. (2018)
Dark Classics in Chemical Neuroscience:
N
,
N
-Dimethyltryptamine (DMT)
. ACS Chemical Neuroscience 9:10, pages 2344-2357.
Crossref
Crossref
Tehseen Noorani, Albert Garcia-Romeu, Thomas C Swift, Roland R Griffiths & Matthew W Johnson. (2018) Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology 32:7, pages 756-769.
Crossref
Crossref
Elisangela G. Cata-Preta, Yasmim A. Serra, Eliseu da C. Moreira-Junior, Henrique S. Reis, Natali D. Kisaki, Matheus Libarino-Santos, Raiany R. R. Silva, Thaísa Barros-Santos, Lucas C. Santos, Paulo C. R. Barbosa, José L. Costa, Alexandre J. Oliveira-Lima, Lais F. Berro & Eduardo A. V. Marinho. (2018) Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment. Frontiers in Pharmacology 9.
Crossref
Crossref
Paulo Cesar Ribeiro Barbosa, Luís F. Tófoli, Michael P. Bogenschutz, Robert Hoy, Lais F. Berro, Eduardo A. V. Marinho, Kelsy N. Areco & Michael J. Winkelman. (2018) Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca. Frontiers in Psychiatry 9.
Crossref
Crossref
Cameron M. Longo & Rabi A. Musah. 2018. Analysis of Drugs of Abuse. Analysis of Drugs of Abuse
125
132
.
Will Lawn, Jaime E. Hallak, Jose A. Crippa, Rafael Dos Santos, Lilla Porffy, Monica J. Barratt, Jason A. Ferris, Adam R. Winstock & Celia J. A. Morgan. (2017) Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey. Scientific Reports 7:1.
Crossref
Crossref
Vanja Dakic, Juliana Minardi Nascimento, Rafaela Costa Sartore, Renata de Moraes Maciel, Draulio B. de Araujo, Sidarta Ribeiro, Daniel Martins-de-Souza & Stevens K. Rehen. (2017) Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Scientific Reports 7:1.
Crossref
Crossref
Michael P. Bogenschutz & Alyssa A. Forcehimes. (2016) Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism. Journal of Humanistic Psychology 57:4, pages 389-414.
Crossref
Crossref
Piera Talin & Emilia Sanabria. (2017) Ayahuasca’s entwined efficacy: An ethnographic study of ritual healing from ‘addiction’. International Journal of Drug Policy 44, pages 23-30.
Crossref
Crossref
Celia Morgan, Amy McAndrew, Tobias Stevens, David Nutt & Will Lawn. (2017) Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use. Current Opinion in Behavioral Sciences 13, pages 71-76.
Crossref
Crossref
Benjamin J. Malcolm & Kelly C. Lee. (2017) Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?. Mental Health Clinician 7:1, pages 39-45.
Crossref
Crossref
S.M. Phipps & O. Grundmann. 2017.
1
44
.
Rafael G dos Santos, Fermanda M Balthazar, José C Bouso & Jaime EC Hallak. (2016) The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. Journal of Psychopharmacology 30:12, pages 1230-1247.
Crossref
Crossref
Elisabet Domínguez-Clavé, Joaquim Soler, Matilde Elices, Juan C. Pascual, Enrique Álvarez, Mario de la Fuente Revenga, Pablo Friedlander, Amanda Feilding & Jordi Riba. (2016) Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Research Bulletin 126, pages 89-101.
Crossref
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jordi Riba, Antônio W. Zuardi & Jaime E. C. Hallak. (2016) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology 6:3, pages 193-213.
Crossref
Crossref
Ede Frecska, Petra Bokor & Michael Winkelman. (2016) The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology 7.
Crossref
Crossref
Michael P. Bogenschutz & Matthew W. Johnson. (2016) Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 250-258.
Crossref
Crossref
L.F. Tófoli & D.B. de Araujo. 2016. Imaging the Addicted Brain. Imaging the Addicted Brain
157
185
.
Fúlvio Rieli Mendes & Dianne da Rocha Prado. 2016. Innovations in the Treatment of Substance Addiction. Innovations in the Treatment of Substance Addiction
51
68
.
Michael P. Bogenschutz & Stephen Ross. 2018. Behavioral Neurobiology of Psychedelic Drugs. Behavioral Neurobiology of Psychedelic Drugs
361
391
.
A.J. Oliveira-Lima, R. Santos, A.W. Hollais, C.A. Gerardi-Junior, M.A. Baldaia, R. Wuo-Silva, T.S. Yokoyama, J.L. Costa, E.L.A. Malpezzi-Marinho, P.C. Ribeiro-Barbosa, L.F. Berro, R. Frussa-Filho & E.A.V. Marinho. (2015) Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice. Physiology & Behavior 142, pages 28-36.
Crossref
Crossref
Rif S. El‐Mallakh, John H. Halpern & Henry David Abraham. 2015. Psychiatry. Psychiatry
1480
1506
.
José Carlos Bouso & Jordi Riba. 2014. The Therapeutic Use of Ayahuasca. The Therapeutic Use of Ayahuasca
95
109
.
Beatriz Caiuby LabateRosa Melo, Glenn Shepard & Clancy Cavnar. (2013) The UDV Religion, Science, and Academic Research. Anthropology of Consciousness 24:2, pages 214-227.
Crossref
Crossref
Charles S. Grob & Marlene Dobkin de Rios. 2013. Clinical Handbook of Adolescent Addiction. Clinical Handbook of Adolescent Addiction
213
222
.
Eduardo E Schenberg. (2013) Ayahuasca and cancer treatment. SAGE Open Medicine 1, pages 205031211350838.
Crossref
Crossref
Daniel I. Brierley & Colin Davidson. (2012) Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 263-272.
Crossref
Crossref
Paulo Cesar Ribeiro Barbosa, Suely Mizumoto, Michael P. Bogenschutz & Rick J. Strassman. (2012) Health status of ayahuasca users. Drug Testing and Analysis 4:7-8, pages 601-609.
Crossref
Crossref
Michael P. Bogenschutz & Jessica M. Pommy. (2012) Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses. Drug Testing and Analysis 4:7-8, pages 543-555.
Crossref
Crossref
Stephen Ross. (2012) Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies. Psychiatric Clinics of North America 35:2, pages 357-374.
Crossref
Crossref
Brian T. Anderson, Beatriz C. Labate, Matthew Meyer, Kenneth W. Tupper, Paulo C.R. Barbosa, Charles S. Grob, Andrew Dawson & Dennis McKenna. (2012) Statement on ayahuasca. International Journal of Drug Policy 23:3, pages 173-175.
Crossref
Crossref
John H. Halpern, Joji Suzuki, Pedro E. Huertas & Torsten Passie. 2011. Addiction Medicine. Addiction Medicine
1083
1098
.
Dale D. Chitwood, Michael L. Weiss & Carl G. Leukefeld. (2008) A Systematic Review of Recent Literature on Religiosity and Substance Use. Journal of Drug Issues 38:3, pages 653-688.
Crossref
Crossref
Hylke Vervaeke. 2008. Drugs en alcohol; Gebruik, misbruik en verslaving. Drugs en alcohol; Gebruik, misbruik en verslaving
369
406
.